Safety & Efficacy of IR-101 in Relapsed/Refractory Neuroblastoma

NCT07067346 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
10
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Sichuan University